Ocean Biomedical, Inc. Contracts & Agreements
51 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (1)
- Human Resources (5)
- Intellectual Property (18)
- Uncategorized (9)
- Third Amendment to Exclusive License Agreement (FRG) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (Anti-CTLA4) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (FRGxPD-1) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (Chit1) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (PfGARP/PfSEA) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Form of Amendment No. 7 to the Common Stock Purchase Agreement by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on April 11, 2022)
- Form of Registration Rights Agreement by and among Ocean Biomedical, Inc. and Poseidon Bio, LLC (Filed With SEC on April 11, 2022)
- Loan Agreement, dated February 22, 2022, by and between the Registrant and Second Street Capital, LLC (Filed With SEC on April 11, 2022)
- Warrant to Subscribe to Common Stock Shares, dated March 8, 2022, issued by the Registrant to Second Street Capital, LLC (Filed With SEC on April 11, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 14, 2022)
- Form of Representatives Warrant (Filed With SEC on February 14, 2022)
- Non-Binding Letter of Intent by and among Ocean Biomedical, Inc. and Alfa Holding GmbH, dated as of February 13, 2022 (Filed With SEC on February 14, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 4, 2022)
- Form of Representatives Warrant (Filed With SEC on February 4, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on February 4, 2022)
- Amendment to Offer Letter by and between the Registrant and Elizabeth Ng, dated as of August 2, 2021 (Filed With SEC on February 4, 2022)
- Amendment to Offer Letter by and between the Registrant and Chirinjeev Kathuria, dated as of August 2, 2021 (Filed With SEC on February 4, 2022)
- Offer Letter, dated as of February 22, 2021, by and between the Registrant and Daniel Behr, as amended on August 2, 2021 (Filed With SEC on February 4, 2022)
- Offer Letter, dated as of February 22, 2021, by and between the Registrant and Gurinder Kalra, as amended on August 2, 2021 (Filed With SEC on February 4, 2022)
- Offer Letter, dated as of February 22, 2021, by and between the Registrant and Inderjote Kathuria, as amended on August 2, 2021 (Filed With SEC on February 4, 2022)
- Offer Letter, dated as of February 22, 2021, by and between the Registrant and Jonathan Heller (Filed With SEC on February 4, 2022)
- Consulting Agreement, dated as of February 22, 2021, by and between the Registrant and Jonathan Kurtis, as amended on August 2, 2021 and December 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (FRG) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (Anti-CTLA4) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (FRGxPD-1) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (Chit1) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (PfGARP/PfSEA) by and between the Registrant and Elkurt Inc., dated as of September 10, 2021 (Filed With SEC on February 4, 2022)
- Amended and Restated Nonexclusive License Agreement for COVID-19 Related Technology, dated as of March 3, 2021 by and between the Registrant and The Board of Trustees of the... (Filed With SEC on February 4, 2022)
- Amended and Restated Exclusive License Agreement, dated as of February 25, 2021, by and between the Registrant and Teton Therapeutics Inc (Filed With SEC on February 4, 2022)
- Amendment No. 1 to the Common Stock Purchase Agreement by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on February 4, 2022)
- Amendment No. 2 to the Common Stock Purchase Agreement by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on February 4, 2022)
- Amendment No. 3 to the Common Stock Purchase Agreement by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on February 4, 2022)
- Amendment No. 4 to the Common Stock Purchase Agreement by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on February 4, 2022)
- Amendment No. 5 to the Common Stock Purchase Agreement by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on February 4, 2022)
- Amendment No. 6 to the Common Stock Purchase Agreement by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on February 4, 2022)
- Specimen Common Stock Certificate of the Registrant (Filed With SEC on July 20, 2021)
- 2021 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on July 14, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on July 14, 2021)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on July 14, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on July 14, 2021)
- Offer Letter, dated as of February 22, 2021, by and between the Registrant and Chirinjeev Kathuria (Filed With SEC on July 14, 2021)
- Form of Indemnification Agreement, by and between the Registrant and each of its directors and officers (Filed With SEC on July 14, 2021)
- Common Stock Purchase Agreement, dated as of June 23, 2021, by and among Ocean Biomedical, Inc. and The Regents of the University of California, as Trustee of the University of... (Filed With SEC on July 14, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 22, 2021)
- Offer Letter, dated as of February 22, 2021, by and between the Registrant and Elizabeth Ng (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (FRG), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (Anti-CTLA4), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (FRGxPD-1), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (Chit1), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (PfGARP/PfSEA), dated as of January 25, 2021, by and between the Registrant and Elkurt Inc., as amended on April 1, 2021 (Filed With SEC on June 22, 2021)
- Nonexclusive License Agreement for COVID-19 Related Technology, dated as of June 25, 2020, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior... (Filed With SEC on June 9, 2021)
